Letter: Digoxin bioavailability: paradoxical increased toxicity on dosage reduction.
作者信息
Leach R H
出版信息
Br Med J. 1975 Aug 16;3(5980):437. doi: 10.1136/bmj.3.5980.437-b.
Abstract
摘要
相似文献
1
Letter: Digoxin bioavailability: paradoxical increased toxicity on dosage reduction.信函：地高辛生物利用度：剂量减少时毒性反而增加的矛盾现象。
Br Med J. 1975 Aug 16;3(5980):437. doi: 10.1136/bmj.3.5980.437-b.
2
Intramuscular injections and bioavailability.
Am J Hosp Pharm. 1977 Sep;34(9):965-8.
3
[Biological availability of digoxin in combination drugs].[复方制剂中地高辛的生物利用度]
Verh Dtsch Ges Inn Med. 1975;81:1666-9.
4
Letter: Therapeutic non-equivalence of digoxin tablets.信件：地高辛片的治疗不等效性。
Br Med J. 1974 Apr 6;2(5909):55. doi: 10.1136/bmj.2.5909.55-b.
5
Dissolution and bioavailability of digoxin tablets.地高辛片的溶出度与生物利用度
J Pharm Pharmacol. 1973 Dec;25(12):968-73. doi: 10.1111/j.2042-7158.1973.tb09988.x.
6
Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.
Acta Pharmacol Toxicol (Copenh). 1977;40 Suppl 3:1-48.
7
Letter: Drug bioavailability.信函：药物生物利用度。
Can Med Assoc J. 1976 Jul 17;115(2):105.
8
Recognition of variable bioavailability as an international problem: a review of the earlier studies.将生物利用度的变异性视为一个国际问题：早期研究综述。
Postgrad Med J. 1974 Nov;50 Suppl 6:14-8.
9
Letter: Discrepancy between solution and bioavailability of digoxin tablets.信函：地高辛片溶液与生物利用度之间的差异
Lancet. 1975 Mar 15;1(7907):629. doi: 10.1016/s0140-6736(75)91907-8.
10
Bioavailability of digoxin.
Lancet. 1972 Sep 30;2(7779):708. doi: 10.1016/s0140-6736(72)92112-5.
本文引用的文献
1
Variation in the biological availability of digoxin.地高辛生物利用度的变化。
Lancet. 1972 Aug 12;2(7772):303-7. doi: 10.1016/s0140-6736(72)92908-x.
Zotero 插件